Found: 15
Select item for more details and to access through your institution.
Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study.
- Published in:
- Technology in Cancer Research & Treatment, 2023, p. 1, doi. 10.1177/15330338231154088
- By:
- Publication type:
- Article
Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by 68Ga-PSMA-11 PET/CT or 11C-Choline PET/CT: impact of postoperative treatments.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 2, p. 399, doi. 10.1007/s00345-020-03220-0
- By:
- Publication type:
- Article
Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 8, p. 1543, doi. 10.1007/s00345-019-02716-8
- By:
- Publication type:
- Article
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2271, doi. 10.3390/cancers12082271
- By:
- Publication type:
- Article
Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00783-w
- By:
- Publication type:
- Article
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 1, p. 92, doi. 10.1111/iju.15066
- By:
- Publication type:
- Article
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay.
- Published in:
- BJU International, 2019, v. 124, n. 1, p. 35, doi. 10.1111/bju.14686
- By:
- Publication type:
- Article
Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-04771-2
- By:
- Publication type:
- Article
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10374-0
- By:
- Publication type:
- Article
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10374-0
- By:
- Publication type:
- Article
Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00781
- By:
- Publication type:
- Article
The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.
- Published in:
- Nutrients, 2023, v. 15, n. 23, p. 4856, doi. 10.3390/nu15234856
- By:
- Publication type:
- Article